These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 15849732
21. Anabolic effect of the traditional Chinese medicine compound tanshinone IIA on myotube hypertrophy is mediated by estrogen receptor. Zhao P, Soukup ST, Hegevoss J, Ngueu S, Kulling SE, Diel P. Planta Med; 2015 May; 81(7):578-85. PubMed ID: 26018796 [Abstract] [Full Text] [Related]
22. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells. Jiao JW, Wen F. Oncol Rep; 2011 Mar; 25(3):781-8. PubMed ID: 21165580 [Abstract] [Full Text] [Related]
23. Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo. Chien SY, Kuo SJ, Chen YL, Chen DR, Cheng CY, Su CC. Mol Med Rep; 2012 Jan; 5(1):282-6. PubMed ID: 22002472 [Abstract] [Full Text] [Related]
24. Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA. Xu Z, Chen L, Xiao Z, Zhu Y, Jiang H, Jin Y, Gu C, Wu Y, Wang L, Zhang W, Zuo J, Zhou D, Luan J, Shen J. Phytomedicine; 2018 Dec 01; 51():58-67. PubMed ID: 30466628 [Abstract] [Full Text] [Related]
25. [Anticancer effect of tanshinone and its mechanisms]. Yuan SL, Wang XJ, Wei YQ. Ai Zheng; 2003 Dec 01; 22(12):1363-6. PubMed ID: 14693071 [Abstract] [Full Text] [Related]
26. Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro. Liu JJ, Lin DJ, Liu PQ, Huang M, Li XD, Huang RW. J Biomed Sci; 2006 Nov 01; 13(6):813-23. PubMed ID: 16955348 [Abstract] [Full Text] [Related]
27. Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells. Pan TL, Hung YC, Wang PW, Chen ST, Hsu TK, Sintupisut N, Cheng CS, Lyu PC. Proteomics; 2010 Mar 01; 10(5):914-29. PubMed ID: 20049856 [Abstract] [Full Text] [Related]
28. A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway. Tian HL, Yu T, Xu NN, Feng C, Zhou LY, Luo HW, Chang DC, Le XF, Luo KQ. Cancer Lett; 2010 Nov 01; 297(1):18-30. PubMed ID: 20494511 [Abstract] [Full Text] [Related]
29. Proapoptotic and TRAIL-sensitizing constituents isolated from Salvia militiorrhiza (Danshen). Chang CC, Lai JS, Tsai CS, Ma SW, Lin JY, Huang LR, Lu CH, Liao EC, Ho TF. J Biosci Bioeng; 2013 Oct 01; 116(4):516-23. PubMed ID: 23660075 [Abstract] [Full Text] [Related]
36. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways. Lin C, Wang L, Wang H, Yang L, Guo H, Wang X. J Cell Biochem; 2013 Sep 01; 114(9):2061-70. PubMed ID: 23553622 [Abstract] [Full Text] [Related]
38. Influence of Tanshinone IIA on the Apoptosis of Human Esophageal Ec-109 Cells. Zhu YQ, Wang BY, Wu F, An YK, Zhou XQ. Nat Prod Commun; 2016 Jan 01; 11(1):17-9. PubMed ID: 26996008 [Abstract] [Full Text] [Related]
39. Tanshinone IIA inhibits Hep-J5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression. Cheng CY, Su CC. Int J Mol Med; 2010 Sep 01; 26(3):379-85. PubMed ID: 20664954 [Abstract] [Full Text] [Related]
40. Tanshinone IIA enhances the effects of TRAIL by downregulating survivin in human ovarian carcinoma cells. Lin JY, Ke YM, Lai JS, Ho TF. Phytomedicine; 2015 Sep 15; 22(10):929-38. PubMed ID: 26321742 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]